ArticleMembranes2026
Regulation of Membrane Association and Downstream Effector Interaction of K-Ras by Its Hypervariable Region.
Article in Membranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The small GTPase Ras, a central switch in signal transduction of cell growth, is a crucial element in the development of many forms of cancer. Recent studies have shown that membrane association of Ras is essential to its downstream effector recruitment and signal transduction. Here we investigate the membrane association and interaction of K-Ras4B, the most frequently found Ras isoform in tumor cells, using all-atom molecular dynamics simulations totaling 8.5 μs. We find that the isoform-specific, farnesylated hypervariable region (HVR) of Ras plays an important role in the organization and oligomerization of its globular domain (G-domain) on the surface of the membrane. We show that the overall pose of the Ras G-domain on the membrane can be determined by its HVR. The HVR thus can control downstream effector binding by positioning the G-domain on the membrane in a specific orientation. Furthermore, we observe that the HVR alone already transiently dimerizes in the membrane and recruits negatively charged phosphatidylserine lipids around the K-Ras isoform-specific poly-lysine region. The observed HVR dimerization potentially can initiate the dimerization of the full K-Ras, which is essential for downstream effector signaling via various pathways. These atomistic details behind the molecular mechanism of the HVR provide novel insight into Ras interaction with membrane and its availability for downstream effectors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.